You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

acute lung injury, molgramostim, GM-CSF, pneumonia, barrier restoration

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

ARDS Trial in Germany (inhaled molgramostim (rhGM-CSF), inhaled )

Active, not recruiting
  • ARDS
  • inhaled molgramostim (rhGM-CSF)
  • inhaled placebo
  • Würzburg, Baden-Würtemberg, Germany
  • +6 more
Oct 27, 2021

Severe Acute Respiratory Syndrome (SARS) Pneumonia, COVID-19 Pneumonia Trial in Germany (Molgramostim nebuliser solution,

Active, not recruiting
  • Severe Acute Respiratory Syndrome (SARS) Pneumonia
  • COVID-19 Pneumonia
  • Molgramostim nebuliser solution
  • Placebo nebuliser solution
  • Dresden, Germany
  • +8 more
Jun 20, 2022

Platinum Sensitive Ovarian Cancer, Ovarian Cancer Trial in United States (FRa peptide plus Adjuvant (GM-CSF), Adjuvant (GM-CSF)

Terminated
Has Results
  • Platinum Sensitive Ovarian Cancer
  • Ovarian Cancer
  • FRα peptide plus Adjuvant (GM-CSF)
  • Adjuvant (GM-CSF) Alone
  • Birmingham, Alabama
  • +17 more
Nov 21, 2022

Ventilator Associated Pneumonia Trial in Acquaviva Delle Fonti, Bari (LactoLevure, Placebo)

Not yet recruiting
  • Ventilator Associated Pneumonia
  • LactoLevure
  • Placebo
  • Acquaviva Delle Fonti, BA, Italy
  • +1 more
Oct 22, 2023

Biomolecular Phenotyping of Lung Transplant Recipients

Recruiting
  • Lung Transplant Failure
  • Sub-phenotyping by biomarkers concentration
  • Milan, Italy
    Fondazione IRCCS Ca'Granda - Ospedale Maggiore Policlinico
Nov 4, 2023

Senstivity and Specificity of Lung Ultrasound for Early

Not yet recruiting
  • Chest Trauma
  • ULTRASOUND
  • (no location specified)
Oct 10, 2023

Autoimmune Pulmonary Alveolar Proteinosis Trial in Worldwide (Molgramostim, Placebo, PARI eFlow nebulizer system)

Completed
Has Results
  • Autoimmune Pulmonary Alveolar Proteinosis
  • Los Angeles, California
  • +29 more
Dec 14, 2022

Pneumonia, Bacterial, Respiratory Failure, COVID-19 Pneumonia Trial in Moscow (Arterial blood gases, Respiratory rate (RR),

Recruiting
  • Pneumonia, Bacterial
  • +2 more
  • Arterial blood gases
  • +7 more
  • Moscow, Russian Federation
    City clinical hospital named after F.I.Inozemtsev, Moscow
Nov 2, 2023

Acute Liver Injury in Patients With Pneumonia

Not yet recruiting
  • Acute Liver Injury
  • Pneumonia
  • Acute Liver Injury
  • Assuit, Egypt
    Faculty Of Medicine
Oct 25, 2023

Incidince of Acute Kidney Injury in Community Acquired Pneumonia

Not yet recruiting
  • Acute Kidney Injury
    • (no location specified)
    Oct 31, 2023

    ALI/ARDS Clinical Sub-phenotyping Study

    Not yet recruiting
    • Acute Lung Injury/Acute Respiratory Distress Syndrome (ARDS)
    • Collect peripheral blood and bronchoalveolar lavage fluid
    • (no location specified)
    Nov 8, 2023

    Malignant Melanoma Trial in United States (UV1, GM-CSF)

    Active, not recruiting
    • Malignant Melanoma
    • Santa Monica, California
    • +3 more
    Nov 16, 2022

    NSCLC, Carcinoma Breast Trial in Suzhou (Vinorelbine, Radiotherapy, PD-1/PD-L1 inhibitor)

    Not yet recruiting
    • Carcinoma, Non-Small-Cell Lung
    • Carcinoma Breast
    • Suzhou, China
      Second Affiliated Hospital of Soochow University
    Oct 29, 2022

    COVID-19 Trial in United States (Gimsilumab, Placebo)

    Completed
    Has Results
    • COVID-19
    • Phoenix, Arizona
    • +32 more
    Dec 10, 2021

    COVID-19 Pneumonia, Acute Lung Injury, ARDS Trial in United States (CERC-002, Placebo)

    Completed
    Has Results
    • COVID-19 Pneumonia
    • +2 more
    • Newport Beach, California
    • +10 more
    Mar 22, 2022

    Smoke Inhalation Injury, Acute Lung Injury Trial in Cairo (Heparin, Normal Saline)

    Recruiting
    • Smoke Inhalation Injury
    • Acute Lung Injury
    • Cairo, Egypt
      Ain Shams University Hospitals
    May 31, 2023

    Carcinoma, Solid Tumor Trial in Suzhou (ADC Combined With Radiotherapy, PD-L1 Sequential GM-CSF and Thymopentin)

    Not yet recruiting
    • Carcinoma
    • Solid Tumor
    • ADC Combined With Radiotherapy, PD-L1 Sequential GM-CSF and Thymopentin
    • Suzhou, China
      Second Affiliated Hospital of Soochow University
    Oct 26, 2023

    Head Neck Cancer, Mucositis Oral, Radiation Toxicity Trial in San Francisco (sargramostim, oral salt and soda mouthwash)

    Completed
    Has Results
    • Head and Neck Cancer
    • +3 more
    • sargramostim
    • oral salt and soda mouthwash
    • San Francisco, California
      University of California, San Francisco
    Jul 9, 2021

    Lung Non-Squamous Non-Small Cell Carcinoma, Stage IV Lung Cancer AJCC v8, Stage IVA Lung Cancer AJCC v8 Trial in Seattle

    Not yet recruiting
    • Lung Non-Squamous Non-Small Cell Carcinoma
    • +3 more
    • CD105/Yb-1/SOX2/CDH3/MDM2-polyepitope Plasmid DNA Vaccine
    • Sargramostim
    • Seattle, Washington
      Fred Hutch/University of Washington Cancer Consortium
    Aug 11, 2022

    Malignant Melanoma Trial in Worldwide (UV1, Sargramostim, Ipilimumab)

    Recruiting
    • Malignant Melanoma
    • UV1
    • +3 more
    • Phoenix, Arizona
    • +39 more
    Aug 16, 2022

    Airway Occlusion Measured During Non-invasive Ventilation to

    Not yet recruiting
    • Healthy Volunteers
    • airway pressure occlusion measurement
    • Buenos Aires, Argentina
      Swiss Medical Group
    Oct 17, 2022

    Advanced Solid Tumor, Refractory Tumor Trial in Suzhou (Thymalfasin, Radiotherapy, PD-1/PD-L1 inhibitor)

    Recruiting
    • Advanced Solid Tumor
    • Refractory Tumor
    • Suzhou, China
      The Second Affiliated Hospital of SchoowUniversity
    Mar 29, 2023

    Hepatitis B, Chronic Trial in Beijing (Granulocyte Macrophage-colony Stimulating Factor, Entecavir)

    Terminated
    • Hepatitis B, Chronic
    • Granulocyte Macrophage-colony Stimulating Factor
    • Entecavir
    • Beijing, Beijing, China
      302 Military Hospital
    Mar 9, 2022

    Autoimmune Pulmonary Alveolar Proteinosis Trial in Worldwide (Molgramostim, Placebo)

    Recruiting
    • Autoimmune Pulmonary Alveolar Proteinosis
    • Little Rock, Arkansas
    • +54 more
    Dec 14, 2022

    Neuroblastoma Trial in New York (Hu3F8, GM-CSF, Isotretinoin)

    Active, not recruiting
    • Neuroblastoma
    • Hu3F8
    • +2 more
    • New York, New York
      Memorial Sloan Kettering Cancer Center
    Jul 1, 2022